About 23andMe
23andMe, headquartered in Sunnyvale, California, is a pioneering biotechnology and research company founded in 2006. The company's mission is to help people access, understand, and benefit from the human genome. As a leader in consumer genetics, 23andMe offers direct-to-consumer genetic testing, providing individuals with insights into their genetic makeup and potential health risks. The company is unique in having multiple FDA authorizations for its genetic health risk reports.
Innovation and Research
23andMe has established the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. This platform has generated over 180 publications that explore the genetic underpinnings of various diseases, conditions, and traits. The insights gained are not only valuable for individuals but also contribute significantly to the global understanding of human genetics.
Therapeutics and Drug Discovery
The company’s research efforts extend into drug discovery through the 23andMe Therapeutics group. This division is actively pursuing innovative drug discovery programs rooted in human genetics across multiple disease areas, including oncology, respiratory, and cardiovascular diseases, among others.
Workplace and Culture
23andMe values a collaborative and inclusive work environment. It has been recognized as one of the top workplaces by the San Francisco Chronicle and one of the best places to work by Comparably. The company's CEO, Anne Wojcicki, has received accolades for her leadership, including being named one of Glassdoor’s top CEOs and one of Comparably’s "Best CEOs for Women".
Joining 23andMe
Working at 23andMe offers an opportunity to be at the forefront of genetic research and healthcare innovation. Employees are part of a dynamic team that is passionate about empowering individuals with genetic insights and advancing the science of genetics for better health outcomes.
